Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression

Cell Metabolism

Volumn 15, Issue 6, 2012, Pages 873-884

  Haas, Joel T ^a   Miao, Ji ^c   Chanda, Dipanjan ^c   Wang, Yanning ^c   Zhao, Enpeng ^c   Haas, Mary E ^c   Hirschey, Matthew ^d   Vaitheesvaran, B ^e   Farese, Robert V ^a,b   Kurland, Irwin J ^e   Graham, Mark ^f   Crooke, Rosanne ^f   Foufelle, Fabienne ^g   Biddinger, Sudha B ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f ISIS PHARMACEUTICALS   (United States)

^g INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CARBOHYDRATE; FRUCTOSE; INSULIN; INSULIN RECEPTOR; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOHYDRATE DIET; CONTROLLED STUDY; FEMALE; FOOD INTAKE; INSULIN METABOLISM; LIPOGENESIS; LIVER CELL; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

MUS;

EID: 84862023939     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2012.05.002     Document Type: Article

References (47)

1. Anai, M., Funaki, M., Ogihara, T., Kanda, A., Onishi, Y., Sakoda, H., Inukai, K., Nawano, M., Fukushima, Y., Yazaki, Y., et al. (1999). Enhanced insulin- stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fatfed rats. Diabetes 48, 158-169. (Pubitemid 29019368)
2. Biddinger, S.B., Almind, K., Miyazaki, M., Kokkotou, E., Ntambi, J.M., and Kahn, C.R. (2005). Effects of diet and genetic background on sterol regulatory element-binding protein-1c, stearoyl-CoA desaturase 1, and the development of the metabolic syndrome. Diabetes 54, 1314-1323. (Pubitemid 40586659)
3. Biddinger, S.B., Hernandez-Ono, A., Rask-Madsen, C., Haas, J.T., Alemán, J.O., Suzuki, R., Scapa, E.F., Agarwal, C., Carey, M.C., Stephanopoulos, G., et al. (2008). Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab. 7, 125-134. (Pubitemid 351168555)
4. Biddinger, S.B., and Kahn, C.R. (2006). From mice to men: insights into the insulin resistance syndromes. Annu. Rev. Physiol. 68, 123-158.
5. Brown, M.S., and Goldstein, J.L. (2008). Selective versus total insulin resistance: a pathogenic paradox. Cell Metab. 7, 95-96. (Pubitemid 351168559)
6. Chen, G., Liang, G., Ou, J., Goldstein, J.L., and Brown, M.S. (2004). Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc. Natl. Acad. Sci. USA 101, 11245-11250. (Pubitemid 39038332)
7. Cusi, K. (2009). Nonalcoholic fatty liver disease in type 2 diabetes mellitus. Curr. Opin. Endocrinol. Diabetes Obes. 16, 141-149.
8. Czech, M.P. (1982). Structural and functional homologies in the receptors for insulin and the insulin-like growth factors. Cell 31, 8-10.
9. Denechaud, P.D., Bossard, P., Lobaccaro, J.M., Millatt, L., Staels, B., Girard, J., and Postic, C. (2008). ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver. J. Clin. Invest. 118, 956-964. (Pubitemid 351364603)
10. Dentin, R., Pégorier, J.P., Benhamed, F., Foufelle, F., Ferré, P., Fauveau, V., Magnuson, M.A., Girard, J., and Postic, C. (2004). Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. J. Biol. Chem. 279, 20314-20326. (Pubitemid 38623477)
11. Dif, N., Euthine, V., Gonnet, E., Laville, M., Vidal, H., and Lefai, E. (2006). Insulin activates human sterol-regulatory-element-binding protein-1c (SREBP-1c) promoter through SRE motifs. Biochem. J. 400, 179-188. (Pubitemid 44763833)
12. Doiron, B., Cuif, M.H., Kahn, A., and Diaz-Guerra, M.J. (1994). Respective roles of glucose, fructose, and insulin in the regulation of the liver-specific pyruvate kinase gene promoter. J. Biol. Chem. 269, 10213-10216. (Pubitemid 24198208)
13. Engelking, L.J., Kuriyama, H., Hammer, R.E., Horton, J.D., Brown, M.S., Goldstein, J.L., and Liang, G. (2004). Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis. J. Clin. Invest. 113, 1168-1175. (Pubitemid 38544102)
14. Foretz, M., Guichard, C., Ferré, P., and Foufelle, F. (1999). Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc. Natl. Acad. Sci. USA 96, 12737-12742. (Pubitemid 29513572)
15. Ginsberg, H.N., Jacobs, A., Le, N.A., and Sandler, J. (1982). Effect of somatostatin- induced suppression of postprandial insulin response upon the hypertriglyceridemia associated with a high carbohydrate diet. J. Clin. Invest. 70, 1225-1233. (Pubitemid 13168003)
16. Guo, S., Copps, K.D., Dong, X., Park, S., Cheng, Z., Pocai, A., Rossetti, L., Sajan, M., Farese, R.V., and White, M.F. (2009). The Irs1 branch of the insulin signaling cascade plays a dominant role in hepatic nutrient homeostasis. Mol. Cell. Biol. 29, 5070-5083.
17. Hegarty, B.D., Bobard, A., Hainault, I., Ferré, P., Bossard, P., and Foufelle, F. (2005). Distinct roles of insulin and liver X receptor in the induction and cleavage of sterol regulatory element-binding protein-1c. Proc. Natl. Acad. Sci. USA 102, 791-796. (Pubitemid 40282744)
18. Horton, J.D., Bashmakov, Y., Shimomura, I., and Shimano, H. (1998). Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc. Natl. Acad. Sci. USA 95, 5987-5992. (Pubitemid 28248951)
19. Jeon, T.I., and Osborne, T.F. (2012). SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol. Metab. 23, 65-72.
20. Johnson, R.J., Segal, M.S., Sautin, Y., Nakagawa, T., Feig, D.I., Kang, D.H., Gersch, M.S., Benner, S., and Sánchez-Lozada, L.G. (2007). Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am. J. Clin. Nutr. 86, 899-906. (Pubitemid 47538288)
21. Kammoun, H.L., Chabanon, H., Hainault, I., Luquet, S., Magnan, C., Koike, T., Ferré, P., and Foufelle, F. (2009). GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J. Clin. Invest. 119, 1201-1215.
22. Khamzina, L., Veilleux, A., Bergeron, S., and Marette, A. (2005). Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology 146, 1473-1481. (Pubitemid 40289337)
23. Leavens, K.F., Easton, R.M., Shulman, G.I., Previs, S.F., and Birnbaum, M.J. (2009). Akt2 is required for hepatic lipid accumulation in models of insulin resistance. Cell Metab. 10, 405-418.
24. Li, S., Brown, M.S., and Goldstein, J.L. (2010). Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc. Natl. Acad. Sci. USA 107, 3441-3446.
25. Matsuzaka, T., Shimano, H., Yahagi, N., Amemiya-Kudo, M., Okazaki, H., Tamura, Y., Iizuka, Y., Ohashi, K., Tomita, S., Sekiya, M., et al. (2004). Insulin-independent induction of sterol regulatory element-binding protein- 1c expression in the livers of streptozotocin-treated mice. Diabetes 53, 560-569. (Pubitemid 38270623)
26. Mayes, P.A. (1993). Intermediary metabolism of fructose. Am. J. Clin. Nutr. 58 (5, Suppl), 754S-765S.
27. Miao, J., Fang, S., Lee, J., Comstock, C., Knudsen, K.E., and Kemper, J.K. (2009). Functional specificities of Brm and Brg-1 Swi/Snf ATPases in the feedback regulation of hepatic bile acid biosynthesis. Mol. Cell Biol. 29, 6170-6181.
28. McGarry, J.D. (1992). What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258, 766-770.
29. Michael, M.D., Kulkarni, R.N., Postic, C., Previs, S.F., Shulman, G.I., Magnuson, M.A., and Kahn, C.R. (2000). Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell 6, 87-97.
30. Ouyang, X., Cirillo, P., Sautin, Y., McCall, S., Bruchette, J.L., Diehl, A.M., Johnson, R.J., and Abdelmalek, M.F. (2008). Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J. Hepatol. 48, 993-999.
31. Petersen, K.F., Laurent, D., Yu, C., Cline, G.W., and Shulman, G.I. (2001). Stimulating effects of low-dose fructose on insulin-stimulated hepatic glycogen synthesis in humans. Diabetes 50, 1263-1268. (Pubitemid 32500157)
32. Porstmann, T., Griffiths, B., Chung, Y.L., Delpuech, O., Griffiths, J.R., Downward, J., and Schulze, A. (2005). PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. Oncogene 24, 6465-6481. (Pubitemid 41486630)
33. Postic, C., Dentin, R., and Girard, J. (2004). Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes Metab. 30, 398-408. (Pubitemid 39648006)
34. Reaven, G.M. (1988). Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37, 1595-1607.
35. Sancak, Y., Peterson, T.R., Shaul, Y.D., Lindquist, R.A., Thoreen, C.C., Bar- Peled, L., and Sabatini, D.M. (2008). The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496-1501. (Pubitemid 351929429)
36. Semple, R.K., Sleigh, A., Murgatroyd, P.R., Adams, C.A., Bluck, L., Jackson, S., Vottero, A., Kanabar, D., Charlton-Menys, V., Durrington, P., et al. (2009). Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J. Clin. Invest. 119, 315-322.
37. Sengupta, S., Peterson, T.R., Laplante, M., Oh, S., and Sabatini, D.M. (2010). mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature 468, 1100-1104.
38. Shimomura, I., Bashmakov, Y., Ikemoto, S., Horton, J.D., Brown, M.S., and Goldstein, J.L. (1999). Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. USA 96, 13656-13661.
39. Shimomura, I., Matsuda, M., Hammer, R.E., Bashmakov, Y., Brown, M.S., and Goldstein, J.L. (2000). Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol. Cell 6, 77-86.
40. Standaert, M.L., Sajan, M.P., Miura, A., Kanoh, Y., Chen, H.C., Farese, R.V., Jr., and Farese, R.V. (2004). Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic (ob/ob and Goto-Kakazaki) liver. Contrasting insulin signaling patterns in liver versus muscle define phenotypes of type 2 diabetic and high fat-induced insulinresistant states. J. Biol. Chem. 279, 24929-24934. (Pubitemid 38756740)
41. Um, S.H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P.R., Kozma, S.C., Auwerx, J., and Thomas, G. (2004). Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431, 200-205. (Pubitemid 39243474)
42. Wan, M., Leavens, K.F., Saleh, D., Easton, R.M., Guertin, D.A., Peterson, T.R., Kaestner, K.H., Sabatini, D.M., and Birnbaum, M.J. (2011). Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c. Cell Metab. 14, 516-527.
43. Williamson, R.M., Price, J.F., Glancy, S., Perry, E., Nee, L.D., Hayes, P.C., Frier, B.M., Van Look, L.A., Johnston, G.I., Reynolds, R.M., and Strachan, M.W.; Edinburgh Type 2 Diabetes Study Investigators. (2011). Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care 34, 1139-1144.
44. Yabe, D., Komuro, R., Liang, G., Goldstein, J.L., and Brown, M.S. (2003). Liverspecific mRNA for Insig-2 down-regulated by insulin: implications for fatty acid synthesis. Proc. Natl. Acad. Sci. USA 100, 3155-3160. (Pubitemid 36356555)
45. Yecies, J.L., Zhang, H.H., Menon, S., Liu, S., Yecies, D., Lipovsky, A.I., Gorgun, C., Kwiatkowski, D.J., Hotamisligil, G.S., Lee, C.H., and Manning, B.D. (2011). Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab. 14, 21-32.
46. Yellaturu, C.R., Deng, X., Park, E.A., Raghow, R., and Elam, M.B. (2009). Insulin enhances the biogenesis of nuclear sterol regulatory element-binding protein (SREBP)-1c by posttranscriptional down-regulation of Insig-2A and its dissociation from SREBP cleavage-activating protein (SCAP).SREBP-1c complex. J. Biol. Chem. 284, 31726-31734.
47. Yen, C.L., Stone, S.J., Koliwad, S., Harris, C., and Farese, R.V., Jr. (2008). Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J. Lipid Res. 49, 2283-2301.